- call +1-201-465-4211
- email sales@mrinsights.biz
Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia.
Scope of the Report:
This report focuses on the Growth Factors (Blood and Tissue) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.
Growth factors are mainly used in the treatment of chronic diseases, such as anemia, renal disorders, cancer, etc. For instance, erythropoietin, which stimulates the growth of Red Blood Cells (RBCs), is used to treat anemia. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) are involved in the stimulation of White Blood Cells (WBCs) in cancer patients. However, abnormal production of growth factors causes several diseases.
The worldwide market for Growth Factors (Blood and Tissue) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Amgen, Inc. (USA)
Bayer HealthCare Pharmaceuticals, Inc. (USA)
Biocon Ltd. (India)
Biogen, Inc. (USA)
BioMimetic Therapeutics LLC (USA)
Biopharm GmbH (Germany)
Bolder BioTechnology, Inc. (USA)
F. Hoffmann-La Roche AG (Switzerland)
Chugai Pharmaceutical Co. Ltd. (Japan)
Genentech, Inc. (USA)
FibroGen, Inc. (USA)
Johnson & Johnson (USA)
Janssen Biotech, Inc. (USA)
Lonza Group (Switzerland)
Merck Serono (Germany)
PeproTech, Inc. (USA)
Reliance GeneMedix Plc (UK)
Sangamo Therapeutics, Inc. (USA)
Sanofi (France)
Scil Proteins GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Wockhardt Ltd. (India)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Tissue Growth Factors
Market Segment by Applications, can be divided into
Hospital
Research lab
There are 15 Chapters to deeply display the global Growth Factors (Blood and Tissue) market.
Chapter 1, to describe Growth Factors (Blood and Tissue) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Growth Factors (Blood and Tissue), with sales, revenue, and price of Growth Factors (Blood and Tissue), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Growth Factors (Blood and Tissue), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Growth Factors (Blood and Tissue) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Growth Factors (Blood and Tissue) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Growth Factors (Blood and Tissue) Introduction
1.2 Market Analysis by Type
1.2.1 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
1.2.2 Tissue Growth Factors
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Research lab
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen, Inc. (USA)
2.1.1 Business Overview
2.1.2 Growth Factors (Blood and Tissue) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer HealthCare Pharmaceuticals, Inc. (USA)
2.2.1 Business Overview
2.2.2 Growth Factors (Blood and Tissue) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocon Ltd. (India)
2.3.1 Business Overview
2.3.2 Growth Factors (Blood and Tissue) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Ltd. (India) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biogen, Inc. (USA)
2.4.1 Business Overview
2.4.2 Growth Factors (Blood and Tissue) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biogen, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioMimetic Therapeutics LLC (USA)
2.5.1 Business Overview
2.5.2 Growth Factors (Blood and Tissue) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BioMimetic Therapeutics LLC (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biopharm GmbH (Germany)
2.6.1 Business Overview
2.6.2 Growth Factors (Blood and Tissue) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biopharm GmbH (Germany) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bolder BioTechnology, Inc. (USA)
2.7.1 Business Overview
2.7.2 Growth Factors (Blood and Tissue) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bolder BioTechnology, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 F. Hoffmann-La Roche AG (Switzerland)
2.8.1 Business Overview
2.8.2 Growth Factors (Blood and Tissue) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 F. Hoffmann-La Roche AG (Switzerland) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Chugai Pharmaceutical Co. Ltd. (Japan)
2.9.1 Business Overview
2.9.2 Growth Factors (Blood and Tissue) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Chugai Pharmaceutical Co. Ltd. (Japan) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Genentech, Inc. (USA)
2.10.1 Business Overview
2.10.2 Growth Factors (Blood and Tissue) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Genentech, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 FibroGen, Inc. (USA)
2.11.1 Business Overview
2.11.2 Growth Factors (Blood and Tissue) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 FibroGen, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Johnson & Johnson (USA)
2.12.1 Business Overview
2.12.2 Growth Factors (Blood and Tissue) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Johnson & Johnson (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Janssen Biotech, Inc. (USA)
2.13.1 Business Overview
2.13.2 Growth Factors (Blood and Tissue) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Janssen Biotech, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Lonza Group (Switzerland)
2.14.1 Business Overview
2.14.2 Growth Factors (Blood and Tissue) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Lonza Group (Switzerland) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merck Serono (Germany)
2.15.1 Business Overview
2.15.2 Growth Factors (Blood and Tissue) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck Serono (Germany) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 PeproTech, Inc. (USA)
2.16.1 Business Overview
2.16.2 Growth Factors (Blood and Tissue) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 PeproTech, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Reliance GeneMedix Plc (UK)
2.17.1 Business Overview
2.17.2 Growth Factors (Blood and Tissue) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Reliance GeneMedix Plc (UK) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Sangamo Therapeutics, Inc. (USA)
2.18.1 Business Overview
2.18.2 Growth Factors (Blood and Tissue) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Sangamo Therapeutics, Inc. (USA) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Sanofi (France)
2.19.1 Business Overview
2.19.2 Growth Factors (Blood and Tissue) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Sanofi (France) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Scil Proteins GmbH (Germany)
2.20.1 Business Overview
2.20.2 Growth Factors (Blood and Tissue) Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Scil Proteins GmbH (Germany) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Teva Pharmaceutical Industries Ltd. (Israel)
2.21.1 Business Overview
2.2.2 Growth Factors (Blood and Tissue) Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Teva Pharmaceutical Industries Ltd. (Israel) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Wockhardt Ltd. (India)
2.22.1 Business Overview
2.22.2 Growth Factors (Blood and Tissue) Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Wockhardt Ltd. (India) Growth Factors (Blood and Tissue) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Growth Factors (Blood and Tissue) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Growth Factors (Blood and Tissue) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Growth Factors (Blood and Tissue) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Growth Factors (Blood and Tissue) Manufacturer Market Share in 2017
3.3.2 Top 6 Growth Factors (Blood and Tissue) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Growth Factors (Blood and Tissue) Market Analysis by Regions
4.1 Global Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Regions
4.1.1 Global Growth Factors (Blood and Tissue) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Growth Factors (Blood and Tissue) Revenue and Market Share by Regions (2013-2018)
4.2 North America Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
4.3 Europe Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
4.5 South America Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
5 North America Growth Factors (Blood and Tissue) by Countries
5.1 North America Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Countries
5.1.1 North America Growth Factors (Blood and Tissue) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Growth Factors (Blood and Tissue) Revenue and Market Share by Countries (2013-2018)
5.2 United States Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
5.3 Canada Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
5.4 Mexico Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
6 Europe Growth Factors (Blood and Tissue) by Countries
6.1 Europe Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Countries
6.1.1 Europe Growth Factors (Blood and Tissue) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Growth Factors (Blood and Tissue) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
6.3 UK Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
6.4 France Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
6.5 Russia Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
6.6 Italy Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Growth Factors (Blood and Tissue) by Countries
7.1 Asia-Pacific Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Growth Factors (Blood and Tissue) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Growth Factors (Blood and Tissue) Revenue and Market Share by Countries (2013-2018)
7.2 China Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
7.3 Japan Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
7.4 Korea Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
7.5 India Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
8 South America Growth Factors (Blood and Tissue) by Countries
8.1 South America Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Countries
8.1.1 South America Growth Factors (Blood and Tissue) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Growth Factors (Blood and Tissue) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
8.3 Argentina Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
8.4 Colombia Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Growth Factors (Blood and Tissue) by Countries
9.1 Middle East and Africa Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Growth Factors (Blood and Tissue) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Growth Factors (Blood and Tissue) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
9.3 UAE Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
9.4 Egypt Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
9.5 Nigeria Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
9.6 South Africa Growth Factors (Blood and Tissue) Sales and Growth Rate (2013-2018)
10 Global Growth Factors (Blood and Tissue) Market Segment by Type
10.1 Global Growth Factors (Blood and Tissue) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Growth Factors (Blood and Tissue) Sales and Market Share by Type (2013-2018)
10.1.2 Global Growth Factors (Blood and Tissue) Revenue and Market Share by Type (2013-2018)
10.2 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) Sales Growth and Price
10.2.1 Global Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) Sales Growth (2013-2018)
10.2.2 Global Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) Price (2013-2018)
10.3 Tissue Growth Factors Sales Growth and Price
10.3.1 Global Tissue Growth Factors Sales Growth (2013-2018)
10.3.2 Global Tissue Growth Factors Price (2013-2018)
11 Global Growth Factors (Blood and Tissue) Market Segment by Application
11.1 Global Growth Factors (Blood and Tissue) Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Research lab Sales Growth (2013-2018)
12 Growth Factors (Blood and Tissue) Market Forecast (2018-2023)
12.1 Global Growth Factors (Blood and Tissue) Sales, Revenue and Growth Rate (2018-2023)
12.2 Growth Factors (Blood and Tissue) Market Forecast by Regions (2018-2023)
12.2.1 North America Growth Factors (Blood and Tissue) Market Forecast (2018-2023)
12.2.2 Europe Growth Factors (Blood and Tissue) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Growth Factors (Blood and Tissue) Market Forecast (2018-2023)
12.2.4 South America Growth Factors (Blood and Tissue) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Growth Factors (Blood and Tissue) Market Forecast (2018-2023)
12.3 Growth Factors (Blood and Tissue) Market Forecast by Type (2018-2023)
12.3.1 Global Growth Factors (Blood and Tissue) Sales Forecast by Type (2018-2023)
12.3.2 Global Growth Factors (Blood and Tissue) Market Share Forecast by Type (2018-2023)
12.4 Growth Factors (Blood and Tissue) Market Forecast by Application (2018-2023)
12.4.1 Global Growth Factors (Blood and Tissue) Sales Forecast by Application (2018-2023)
12.4.2 Global Growth Factors (Blood and Tissue) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Growth Factors (Blood and Tissue) Picture
Table Product Specifications of Growth Factors (Blood and Tissue)
Figure Global Sales Market Share of Growth Factors (Blood
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
